Chugai Pharmaceutical
4519.T
£37.29
Share price
-0.39%
Change (1 day)
16.37%
Change (1 year)
Categories
Revenue for Chugai Pharmaceutical (4519.T)
Revenue in 2023: £6.17 Billion
According to Chugai Pharmaceutical's latest financial reports the company's current revenue (TTM 
) is £5.38 Billion. In 2023 the company made a revenue of £6.17 Billion a decrease over the revenue in the year 2022 that were of £7.93 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Chugai Pharmaceutical from 2009 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 | £6.17 B | -22.26% |
| 2022 | £7.93 B | 20.44% |
| 2021 | £6.58 B | 20.84% |
| 2020 | £5.45 B | 13.59% |
| 2019 | £4.80 B | 15.81% |
| 2018 | £4.14 B | 17.71% |
| 2017 | £3.52 B | -4.32% |
| 2016 | £3.68 B | 31.95% |
| 2015 | £2.78 B | 2.1% |
| 2014 | £2.73 B | 5.79% |
| 2013 | £2.58 B | -12.76% |
| 2012 | £2.96 B | -2.24% |
| 2011 | £3.02 B | 6.09% |
| 2010 | £2.85 B | 1.18% |
| 2009 | £2.82 B |